Actively Recruiting
Electrical Stimulation of the Mandibular Nerve for Pain and Function Management in Temporomandibular Disorders
Led by OrigenKinesis fisioterapia · Updated on 2025-08-05
40
Participants Needed
1
Research Sites
167 weeks
Total Duration
On this page
Sponsors
O
OrigenKinesis fisioterapia
Lead Sponsor
U
Universidad Rey Juan Carlos
Collaborating Sponsor
AI-Summary
What this Trial Is About
Temporomandibular disorders (TMD) encompass dysfunction and pain of the masticatory muscles and temporomandibular joint (TMJ). Pain in the TMJ, restricted jaw movement, and joint sounds are common conditions in this disorder. This can impact patients' ability to perform daily activities such as eating, speaking, laughing, or yawning, significantly affecting their quality of life. The TMJ and masticatory muscles are innervated by the auriculotemporal branch and the mandibular nerve (V3), a branch of the trigeminal nerve. An estimated 60% to 70% of the population shows signs of TMD, of which up to 12% report intense symptoms requiring treatment. Percutaneous electrical nerve stimulation (PENS) could be a clinically relevant therapy in TMD patients applied through minimally invasive physiotherapy. To our knowledge, there are no trials evaluating the non-surgical clinical efficacy of PENS on the mandibular nerve. The project's objective is to assess the effectiveness of PENS on the mandibular nerve in this type of condition.
CONDITIONS
Official Title
Electrical Stimulation of the Mandibular Nerve for Pain and Function Management in Temporomandibular Disorders
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with local myofascial pain and/or increased tension in the masticatory muscles.
- Diagnosed with myofascial pain from temporomandibular disorder (TMD) according to RDC/TMD.
- No temporomandibular disc displacement with or without reduction.
- Pain in masticatory muscles with limited mouth opening less than 40 mm.
- Good general health without chronic diseases affecting the temporomandibular joint or muscles.
- Provided written consent to participate in the study.
You will not qualify if you...
- Injury to the face or head during study participation.
- Previous surgical procedures in the craniocervical region or degenerative neurological diseases.
- Sudden illness preventing study participation.
- Desire to withdraw from the study.
- Symptoms evolving for less than 2 weeks.
- Inability to understand instructions or sign informed consent.
- Minor patients.
- Regular use of muscle relaxants, anticonvulsants, antidepressants, or anxiolytics.
- Facial paralysis.
- Presence of dental-origin infectious or inflammatory disease.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Origenkinesis Fisioterapia
Alcorcón, Madrid, Spain, 28925
Actively Recruiting
Research Team
H
Hector Mardomingo Medialdea, Phd
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here